SHG
SINGHEALTH FPO [SHG]
Healthcare · ASX Small Cap
$0.1950 -4.9%
Updated 26 Mar 2026 · Scores refresh every scan
⚠ Funding Risk — Cash runway under 4 quarters. Capital raise or funding may be required.
Score Breakdown
Technical37
Catalyst55
Sentiment50
Fundamental59
Momentum46
Risk Gate50
Get alerts when SHG's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI drifting toward oversold territory — worth watching
- MACD momentum is losing steam
- Stochastic is deep in oversold territory — bounce conditions forming
- Drifting lower — down 4.9% over the last 5 days
- Lagging the Small Ords index — relative strength of 0.82, underperforming its peers
- Volatility is contracting — like a spring being compressed, breakouts often follow
- Low cash runway (3 quarters) - dilution risk
- 4C filed 2026-01-26
- Very high P/S ratio (67.3x)
- Strong revenue growth (+536%)
- Near 52-week low (10% of range)
- Small-cap ($20-100M)
- Sentiment is mixed — no strong consensus either way
- Revenue growing at +536% — the top line is moving in the right direction
- Beneish M-Score -0.25 > -1.78: likely earnings manipulation
- RBA hiking (-3pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Below the 200-day average — the long-term trend is still working against it
- Not enough chatter to gauge sentiment — defaulting to neutral
- The bigger volume days are the down days — volume-weighted momentum is negative (-0.30%/day)
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about SHG
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Appendix 3Y - Change of Director's Interest Notice
NONE Change of Registered Office and Place of Business
NONE Appendix 4D Half Yearly Report and Accounts
LOW Quarterly Activities/Appendix 4C Cash Flow Report
Announcement tone +5pts
Recent ASX Announcements
| 2026-03-23 | Appendix 3Y - Change of Director's Interest Notice |
| 2026-02-27 | Change of Registered Office and Place of Business |
| 2026-02-23 | Appendix 4D Half Yearly Report and Accounts PRICE SENSITIVE |
| 2026-01-26 | Quarterly Activities/Appendix 4C Cash Flow Report PRICE SENSITIVE |
Key Metrics
$64.7M
Market Cap
374K
Avg Volume
1.6x
Vol Ratio
$0.18 — $0.42
52-Week Range
N/A
Short Interest
2 qtrs
Cash Runway
-90.1%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 69% |
| L | Leader vs Laggard | laggard | RS: -5 |
| I | Institutional Sponsorship | weak | Inst: 2% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #97 of 117 · Sector avg: 46
View all Healthcare signals →Track SHG and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required